.jpg)
Our Mission
The Psychedelic Medicine Coalition (PMC) is a DC-based, multi-industry 501(C)6 organization with the mission to improve the commercial and regulatory space for novel and alternative treatments to mental health affiliations.
Our Initiatives
PMC engages in conversations with federal stakeholders to spur the creation of federal dollars for clinical psychedelic research studies for industry and universities.
PMC hosts Congressional briefings, develops traditional government affairs advocacy campaigns, provides resources such as a policy analysis and educational pamphlets, and engages in a consensus-driven approach to advance the psychedelic research space.
PMC is not a decriminalization-focused organization. PMC is principally engaged in federal and state-level efforts to increase access to sponsored research & development efforts.
PMC hosts Congressional briefings, develops traditional government affairs advocacy campaigns, provides resources such as a policy analysis and educational pamphlets, and engages in a consensus-driven approach to advance the psychedelic research space.
PMC is not a decriminalization-focused organization. PMC is principally engaged in federal and state-level efforts to increase access to sponsored research & development efforts.
Melissa
Melissa Lavasani is Founder and Chief Executive Officer of Washington, DC-based Psychedelic Medicine Coalition, a national association committed to creating and protecting access to psychedelic medicines through advocacy and education on a federal level. Inspired by her own experience of a working mother using psychedelics to heal her severe postpartum depression, Melissa championed Initiative 81, the Entheogenic Plant and Fungus Policy Act of 2020, which broke records as the largest ballot initiative win in Washington DC's history with 76% approval.
Through Psychedelic Medicine Coalition, Melissa educates lawmakers and advocates for policies that support research and safe, equitable access to psychedelics at the federal and state level. Melissa is also Founder and President of the Psychedelic Medicine Political Action Committee, a Founding Board Member of the Psychedelics and Healing Initiative at the Global Wellness Institute, and on the Advisory Boards of Drugs over Dinner and Universal Ibogaine.
Born in Washington, DC to Iranian immigrants, Melissa has a Bachelor’s degree in Economics from Macalester College, a Masters degree in Management from the University of Denver, and a Masters in Public Policy from George Mason University. As a devoted wife and mother, Melissa cherishes her free time, which she spends playing with her children, fly fishing, and showering love on her beloved pit bull, Gus. Melissa's bold leadership and unwavering commitment to this cause make her an inspiring force for change in the world.
Through Psychedelic Medicine Coalition, Melissa educates lawmakers and advocates for policies that support research and safe, equitable access to psychedelics at the federal and state level. Melissa is also Founder and President of the Psychedelic Medicine Political Action Committee, a Founding Board Member of the Psychedelics and Healing Initiative at the Global Wellness Institute, and on the Advisory Boards of Drugs over Dinner and Universal Ibogaine.
Born in Washington, DC to Iranian immigrants, Melissa has a Bachelor’s degree in Economics from Macalester College, a Masters degree in Management from the University of Denver, and a Masters in Public Policy from George Mason University. As a devoted wife and mother, Melissa cherishes her free time, which she spends playing with her children, fly fishing, and showering love on her beloved pit bull, Gus. Melissa's bold leadership and unwavering commitment to this cause make her an inspiring force for change in the world.
Psychedelic Medicine Coalition is the only DC-based member association focused on psychedelic policy.
We believe natural psychedelic medicines and their synthetic relatives hold vast potential as tools for improving the health and wellness of individuals and their communities.
Together, with our members, we foster pragmatic and diverse conversations at the local, state, and federal levels that seek to advance public policies that integrate psychedelic therapies into our societal frameworks.
With an emphasis on science and evidence-based research, our efforts are dramatically changing the way lawmakers view psychedelic medicines.
Be in the Know
Subscribe to our Newsletter
Sign up with your email address to receive weekly news and updates from Psychedelic Medicine Coalition.
Oops! Something went wrong while submitting the form.
.jpg)
